Anna Brózik

647 total citations
17 papers, 536 citations indexed

About

Anna Brózik is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Anna Brózik has authored 17 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 4 papers in Surgery. Recurrent topics in Anna Brózik's work include Drug Transport and Resistance Mechanisms (9 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Cholesterol and Lipid Metabolism (4 papers). Anna Brózik is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Cholesterol and Lipid Metabolism (4 papers). Anna Brózik collaborates with scholars based in Hungary, South Korea and France. Anna Brózik's co-authors include Mária Magócsi, Gergely Szakács, Ágota Apáti, Judit Jánossy, Balázs Sarkadi, Zsuzsa Erdei, Tamás Hegedűs, Csilla Hegedüs, Csilla Özvegy‐Laczka and Katalin Kiss and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Anna Brózik

17 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Brózik Hungary 13 291 212 59 57 53 17 536
Zhiqin Li China 14 265 0.9× 117 0.6× 43 0.7× 61 1.1× 73 1.4× 42 716
Maria Teresa Rizzo United States 13 254 0.9× 128 0.6× 74 1.3× 33 0.6× 56 1.1× 40 601
Snehalata A. Pawar United States 14 286 1.0× 82 0.4× 42 0.7× 19 0.3× 53 1.0× 20 525
Silvia Boffo United States 14 323 1.1× 176 0.8× 73 1.2× 34 0.6× 57 1.1× 30 612
Monica Cubillos‐Rojas Spain 14 426 1.5× 131 0.6× 33 0.6× 49 0.9× 58 1.1× 25 611
Virginia Novaro Argentina 19 375 1.3× 246 1.2× 23 0.4× 26 0.5× 102 1.9× 42 907
J Turner United Kingdom 12 510 1.8× 101 0.5× 56 0.9× 16 0.3× 45 0.8× 16 797
Anett Illing Germany 14 263 0.9× 127 0.6× 30 0.5× 21 0.4× 200 3.8× 21 705
Runxia Gu China 10 132 0.5× 111 0.5× 64 1.1× 23 0.4× 91 1.7× 41 412

Countries citing papers authored by Anna Brózik

Since Specialization
Citations

This map shows the geographic impact of Anna Brózik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Brózik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Brózik more than expected).

Fields of papers citing papers by Anna Brózik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Brózik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Brózik. The network helps show where Anna Brózik may publish in the future.

Co-authorship network of co-authors of Anna Brózik

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Brózik. A scholar is included among the top collaborators of Anna Brózik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Brózik. Anna Brózik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Brózik, Anna, Zsolt Matula, Adrienn Borsy, et al.. (2020). Precision-engineered reporter cell lines reveal ABCG2 regulation in live lung cancer cells. Biochemical Pharmacology. 175. 113865–113865. 15 indexed citations
2.
Tordai, Hedvig, et al.. (2017). ABCMdb reloaded: updates on mutations in ATP binding cassette proteins. Database. 2017(1). 10 indexed citations
3.
Matula, Zsolt, Andrea H. Németh, Péter Lőrincz, et al.. (2016). The Role of Extracellular Vesicle and Tunneling Nanotube-Mediated Intercellular Cross-Talk Between Mesenchymal Stem Cells and Human Peripheral T Cells. Stem Cells and Development. 25(23). 1818–1832. 46 indexed citations
4.
Tóth, Attila, Anna Brózik, Gergely Szakács, Balázs Sarkadi, & Tamás Hegedűs. (2015). A Novel Mathematical Model Describing Adaptive Cellular Drug Metabolism and Toxicity in the Chemoimmune System. PLoS ONE. 10(2). e0115533–e0115533. 4 indexed citations
5.
Kiss, Katalin, Nóra Kucsma, Anna Brózik, et al.. (2015). Role of the N-terminal transmembrane domain in the endo-lysosomal targeting and function of the human ABCB6 protein. Biochemical Journal. 467(1). 127–139. 38 indexed citations
6.
Kiss, Katalin, Anna Brózik, Nóra Kucsma, et al.. (2012). Shifting the Paradigm: The Putative Mitochondrial Protein ABCB6 Resides in the Lysosomes of Cells and in the Plasma Membrane of Erythrocytes. PLoS ONE. 7(5). e37378–e37378. 80 indexed citations
7.
Hegedüs, Csilla, Anna Brózik, Ildikó Kasza, et al.. (2012). PI3-kinase and mTOR inhibitors differently modulate the function of the ABCG2 multidrug transporter. Biochemical and Biophysical Research Communications. 420(4). 869–874. 13 indexed citations
8.
Erdei, Zsuzsa, Balázs Sarkadi, Anna Brózik, et al.. (2012). Dynamic ABCG2 expression in human embryonic stem cells provides the basis for stress response. European Biophysics Journal. 42(2-3). 169–179. 24 indexed citations
9.
Boussac, Hugues de, Tamás I. Orbán, György Várady, et al.. (2012). Stimulus-induced expression of the ABCG2 multidrug transporter in HepG2 hepatocarcinoma model cells involves the ERK1/2 cascade and alternative promoters. Biochemical and Biophysical Research Communications. 426(2). 172–176. 14 indexed citations
10.
Brózik, Anna, Csilla Hegedüs, Zsuzsa Erdei, et al.. (2011). Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?. Expert Opinion on Drug Metabolism & Toxicology. 7(5). 623–642. 98 indexed citations
11.
Bors, András, Anna Brózik, Zsuzsanna Újfaludi, et al.. (2007). External cell control polymerase chain reaction: replacing internal standards with an unbiased strategy for quantitative polymerase chain reaction normalization. Analytical Biochemistry. 372(2). 261–263. 2 indexed citations
12.
Magócsi, Mária, E. Sylvester Vizi, Zsolt Selmeczy, Anna Brózik, & Judith Szelényi. (2007). Multiple G‐protein‐coupling specificity of β‐adrenoceptor in macrophages. Immunology. 122(4). 503–513. 25 indexed citations
13.
Szelényi, Judith, Zsolt Selmeczy, Anna Brózik, Dávid Medgyesi, & Mária Magócsi. (2006). Dual β-adrenergic modulation in the immune system: Stimulus-dependent effect of isoproterenol on MAPK activation and inflammatory mediator production in macrophages. Neurochemistry International. 49(1). 94–103. 31 indexed citations
14.
Brózik, Anna, András Bors, Hajnalka Andrikovics, et al.. (2006). Reduction of Bcr‐Abl Function Leads to Erythroid Differentiation of K562 Cells via Downregulation of ERK. Annals of the New York Academy of Sciences. 1090(1). 344–354. 12 indexed citations
15.
Apáti, Ágota, Judit Jánossy, Anna Brózik, Pál I. Bauer, & Mária Magócsi. (2003). Calcium Induces Cell Survival and Proliferation through the Activation of the MAPK Pathway in a Human Hormone-dependent Leukemia Cell Line, TF-1. Journal of Biological Chemistry. 278(11). 9235–9243. 58 indexed citations
16.
Apáti, Ágota, Judit Jánossy, Anna Brózik, & Mária Magócsi. (2003). Effects of Intracellular Calcium on Cell Survival and the MAPK Pathway in a Human Hormone‐Dependent Leukemia Cell Line (TF‐1). Annals of the New York Academy of Sciences. 1010(1). 70–73. 20 indexed citations
17.
Kolonics, Attila, Ágota Apáti, Judit Jánossy, et al.. (2001). Activation of Raf/ERK1/2 MAP kinase pathway is involved in GM-CSF-induced proliferation and survival but not in erythropoietin-induced differentiation of TF-1 cells. Cellular Signalling. 13(10). 743–754. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026